You are here

TAS::75 0894::TAS SBIR PHASE II (PHS 2008-1,TOPIC 33 ) LIMAGING, LLC

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: N44HD100012
Agency Tracking Number: N44HD100012
Amount: $499,799.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: NICHD
Solicitation Number: N/A
Timeline
Solicitation Year: 2011
Award Year: 2011
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
12009 DISTANT THUNDER TRL
CLARKSVILLE, MD 21029-1690
United States
DUNS: 827092227
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 HUIPING LI
 (301) 728-0694
 HUIPING.LI@GMAIL.COM
Business Contact
 HUIPING LI
Phone: (301) 728-0694
Email: HUIPING.LI@GMAIL.COM
Research Institution
 Stub
Abstract

Under Phase I of the project (SBIR PHS 2008-1, "Development of Methodology for Measuring and Enhancing Compliance for Medications, Topic 33), the MobileMedMinder was successfully demonstrated. Phase II will involve collaboration to develop and commercialize the MobileMedMinder. This product will allow users to enroll and verify medication intake using the existing mobile devices, and link seemlessly to web through wireless. MobileMedMinder will provide the following: 1) automatic or simi-automatic entryof medication information through Medscanning, electronic pick lists, voice recognition. 2) Real-time communication with an on-line server where medication can be monitored and recommendations made from automated systems, caregivers or physicians directlyor through social networking solutions. 3) If successful, MobileMedMinder can be extended as a mobile platform for chronic disease management system, such as diabetes, depression, hypertension, etc. A user-centered usability testing and subject study atthe Ohio State University Medical Center managed by collaborator, Robert M. Guthrie, M.D., is planned to provide a comprehensive, non-intrusive, portable solution in support of medication compliance. The ultimate goal is to develop a product for use by patients on a mobile/web platform to promote medication compliance and behavior change that can be subsequently commercialized.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government